Two-Dimensional MR Spectroscopy of Minimal Hepatic Encephalopathy and Neuropsychological Correlates In Vivo

Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California 90095-1721, USA.
Journal of Magnetic Resonance Imaging (Impact Factor: 2.79). 07/2010; 32(1):35-43. DOI: 10.1002/jmri.22216
Source: PubMed

ABSTRACT To evaluate regional cerebral metabolic and structural changes in patients with minimal hepatic encephalopathy (MHE) using two-dimensional (2D) MR spectroscopy (MRS) and T( (1) )-weighted MRI, to correlate the observed MR changes with neuropsychological (NP) test scores, and to compare the diagnostic accuracy of MRI, 2D MRS, and NP tests in discriminating between patients and healthy subjects.
Thirty-three MHE patients and 30 healthy controls were investigated. The 2D localized correlated spectroscopy (L-COSY) was performed in the frontal and occipital brain on a 1.5 Tesla (T) MR scanner. The NP test battery included 15 tests, grouped into 6 cognitive domains. Globus pallidus signal intensities were calculated from T(1)-weighted images.
The 2D MRS showed significant differences in ratios of the following metabolite(s) peaks with respect to creatine (Cr): decreased myo-inositol (mI), choline (Ch), mICh, and increased (glutamate plus glutamine) (Glx) in patients compared with healthy subjects in both occipital and frontal lobes. Frontal lobe taurine also showed a decline in patients. The NP test results revealed declines in cognitive speed, motor function, executive function, and global cognitive status. Significant correlations were found between the altered metabolites and NP tests. Alteration in the mICh/Cr ratio was noted as a powerful discriminant between healthy subjects and the patients.
The study demonstrates that relative metabolite levels determined by 2D MRS, in particular mICh/Cr, provide the best diagnostic prediction for MHE. The results suggest that depletions of myo-inositol, choline and taurine with respect to creatine correlate with measures of neuropsychological impairment.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction The aim of this work was to detect minimal hepatic encephalopathy (minHE) in children with diffusion-weighted MR imaging (DWI) and proton magnetic resonance spectroscopy (H-1-MRS) of the brain. Methods Prospective study conducted upon 30 consecutive children (age range 6-16 years, 21 boys and 9 girls) with liver cirrhosis and 15 age-and sex-matched healthy control children. Patients with minHE (n=17) and with no minHE (n=13) groups and control group underwent DWI, (HMRS)-H-1, and neuropsychological tests (NPTs). The glutamate or glutamine (Glx), myoinositol (mI), choline (Cho), and creatine (Cr) at the right ganglionic region were determined at H-1-MRS. The apparent diffusion coefficient (ADC) value and metabolic ratios of Glx/Cr, mI/Cr, and Cho/Cr were calculated. Results There was elevated ADC value and Glx/Cr and decreased mI/CI and Ch/Cr in patients with minHE compared to no minHE and control group. There was significant difference between minHE, no minHE, and control group in the ADC value (P=0.001 for all groups), GLx/Cr (P=0.001 for all groups), mI/Cr (P=0.004, 0.001, and 0.001, respectively), Ch/Cr (P=0.001 for all groups), and full-scale IQ of NPT (P=0.001, 0.001, and 0.143, respectively). The NPT of minHE had negative correlation with ADC value (r=-0.872, P=0.001) and GLx/Cr (r=-0.812, P=0.001) and positive correlation with mI/Cr (r=0.732, P=0.001). Conclusion DWI and H-1-MRS are imaging modalities that can detect minHE in children with liver cirrhosis and correlate well with parameters of NPT.
    Neuroradiology 07/2014; 56(10). DOI:10.1007/s00234-014-1409-0 · 2.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The term hepatic encephalopathy (HE) covers a wide spectrum of neuropsychiatric abnormalities caused by portal-systemic shunting. The diagnosis requires demonstration of liver dysfunction or portal-systemic shunts and exclusion of other neurologic disorders. Most patients with this condition have liver dysfunction caused by cirrhosis, but it also occurs in patients with acute liver failure and less commonly, in patients with portal-systemic shunts that are not associated with hepatocellular disease. Various magnetic resonance (MR) techniques have improved our knowledge about the pathophysiology of HE. Proton MR spectroscopy and T1-weighted imaging can detect and quantify accumulations of brain products that are normally metabolized or eliminated such as glutamine and manganese. Other MR techniques such as T2-weighted and diffusion-weighted imaging can identify white matter abnormalities resulting from disturbances in cell volume homeostasis secondary to brain hyperammonemia. Partial or complete recovery of these abnormalities has been observed with normalization of liver function or after successful liver transplantation. MR studies have undoubtedly improved our understanding of the mechanisms involved in the pathogenesis of HE, and some findings can be considered biomarkers for monitoring the effects of therapeutic measures focused on correcting this condition.
    04/2014; 35(2):136-52. DOI:10.1053/j.sult.2013.09.008
  • [Show abstract] [Hide abstract]
    ABSTRACT: The 2D NMR has great potential for routine use in organic chemistry, biochemistry and structural biology. The 2D correlated spectroscopy (COSY) and 2D nuclear Overhauser enhancement (NOE) spectroscopy are particularly powerful techniques for studies of scalar coupling connectivity and spatial connectivity. Here we present the 3-bond spatial connectivity of brain metabolites using in vitro 2D COSY and 2D NOE spectroscopy. The 2D spectra were obtained using 500 MHz NMR from solution of brain metabolites. In this study, we showed the 3-bond and spatial connectivity of brain metabolites detected by scalar coupling and dipolar NOE interaction. Our results may be helpful in promoting better understanding of the interactions in corresponding protons in each of metabolite and provide basic information for structure determination of neurochemicals.
    Neurochemical Journal 01/2014; 8(1). DOI:10.1134/S1819712414010085 · 0.19 Impact Factor